Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey

Japanese Journal of Infectious Diseases

Volumn 61, Issue 6, 2008, Pages 490-493

  Gulay, Zeynep ^a   Ozbek, Ozgen Alpay ^a   Bicmen, Meral ^a   Gur, Deniz ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PROTEIN ERM; PROTEIN MEF; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MEFA PROTEIN, STREPTOCOCCUS; MEMBRANE PROTEIN; METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC); DRUG EFFECT; GENETICS; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYLOGENY; PNEUMOCOCCAL INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; TURKEY;

EID: 58149380785     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. McGee, L., Klugman, K.P., Wasas, A., et al. (2001): Serotype 19F multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm (B) and mef (A)) in South Africa. Antimicrob. Agents Chemother., 45, 1595-1598.
2. Schmitz, F.J., Perdikouli, M., Beeck, A., et al. (2001): Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1911 clinical European Streptococcus pneumoniae isolates. Int. J. Antimicrob. Agents, 18, 433-436.
3. Ko, K.S. and Song, J.H. (2004): Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm (B) and mef (A) genes. J. frifect. Dis., 190, 739-747.
4. Weisblum, B. (1995): Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother., 39, 577-585.
5. Sutcliffe, J., Tait-Kamradt, A. and Wondrack, L. (1996): Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother., 40, 1817-1824.
6. Farrell, D.J., Douthwaite, S., Morrissey, I., et al. (2003): Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob. Agents Chemother., 47, 1777-1783.
7. Clinical and Laboratory Standards Institute (2006): Performance standards for antimicrobial disk susceptibility tests: 9th approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, Pa.
8. Clinical and Laboratory Standards Institute (2005): Performance standards for antimicrobial susceptibility testing: 16th informational supplement, M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
9. Montanari, M.P., Mingoia, M., Giovanetti, E., et al. (2001): Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J. Clin. Microbiol., 39, 1311-1315.
10. Sutcliffe, J., Grebe, T., Tait-Kamradt, A., et al. (1996): Detection of erythromycin-resistance determinants by PCR. Antimicrob. Agent Chemother., 40, 2562-2566.
11. McGee, L., McDougal, L., Zhou, J., et al. (2001): Nomenclature of major antimicrobial-resistant clones of Streptococus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol., 39, 2565-2571.
12. Soll, D.R. (2000): The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev., 13, 332-370.
13. Erdem, H. and Sener, B. (2008): Pneumococcal seroepidemiology in Turkey: implications for vaccine coverage. Vaccine, 26, 1271-1273.
14. Sener, B., McGee, L., Pinar, A., et al. (2006): Genomic backgounds of drug-resistant Streptococcus pneumoniae in Ankara, Turkey: identification of emerging new clones. Microb. Drug Resist., 12, 109-114.
15. Sener, B., Koseoglu, O., Gur, D., et al. (2005): Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey. J. Chemother., 17, 31-35.
16. Toltzis, P., Dut, M., O'Riordan, M.A., et al. (2006): Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American City. Pediatr. Infect. Dis. J., 25, 19-24.
17. Amezega, M.R., Carter, P.E., Cash, P., et al. (2002): Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J. Clin. Microbiol., 40, 3313-3318.
18. Reinert, R.R., Wild, A., Appelbaum, P.C., et al. (2003): Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob. Agents Chemother., 47, 2319-2322.
19. Nagai, K., Appelbaum, P.C., Davies, T.A., et al. (2002): Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrob. Agents Chemother., 46, 371-377.